Extensive preclinical evaluation of lutetium-177-labeled PSMA-specific tracers for prostate cancer radionuclide therapy.

Purpose: Various radiolabeled prostate-specific membrane antigen (PSMA)–targeting tracers are clinically applied for prostate cancer (PCa) imaging and targeted radionuclide therapy. The PSMA binding affinities, biodistribution, and DNA-damaging capacities of these radiotracers have not yet been comp...

Descripción completa

Detalles Bibliográficos

Publicado en:	European Journal of Nuclear Medicine & Molecular Imaging Vol. 48; no. 5; pp. 1339 - 1351
Autores principales:	Ruigrok, Eline A. M., van Vliet, Nicole, Dalm, Simone U., de Blois, Erik, van Gent, Dik C., Haeck, Joost, de Ridder, Corrina, Stuurman, Debra, Konijnenberg, Mark W., van Weerden, Wytske M., de Jong, Marion, Nonnekens, Julie
Formato:	Journal Article
Publicado:	Springer Nature May2021
Acceso en línea:	Ver este registro en EBSCOhost